Why the study?
The study aimed to determine the outcome of alcohol septal ablation in 20 patients from a single centre in Iraq.
Does alcohol septal ablation improve clinical and echocardiographic outcomes in highly symptomatic patients under 60 years with hypertrophic obstructive cardiomyopathy?
Does alcohol septal ablation improve clinical and echocardiographic outcomes in highly symptomatic patients under 60 years with hypertrophic obstructive cardiomyopathy?
Alcohol septal ablation is a safe and effective treatment for younger (<60 years) highly symptomatic patients with HOCM, significantly improving symptoms and hemodynamics with an acceptable pacemaker rate.
Alcohol septal ablation was associated with symptom relief in young HOCM patients; leaves open need for RCTs to guide practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Assim et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: